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degree to which health problems interfere with ability to perform
job roles. The WPQ includes physical, mental (concentration),
time (interruptions and adherence to schedule) and output
(ability to handle workload) scales and a WPQ Index is com-
puted to estimate overall productivity loss. In MATRIX, WPQ
scores were compared to the King’s Health Questionnaire
(KHQ), a validated OAB-speciﬁc quality of life (QOL) instru-
ment. We examined the relationship between WPQ scores and
conceptually-related KHQ domains at baseline, and the sensi-
tivity of the WPQ to change in related KHQ measures at 3
months. RESULTS: A total of 1112 employed OAB patients were
enrolled in MATRIX, from 327 US sites. The number of
responses available for each scale at baseline were: time (n = 830,
75%); physical (n = 866, 78%); mental (n = 818, 74%); output
(n = 814, 73%). A WPQ Index was computable for 740 partic-
ipants. Spearman correlations between the KHQ physical limi-
tations domain and the WPQ physical scale was 0.297, and
between the KHQ role limitations and WPQ index score was
0.356. The WPQ appears to be sensitive to change over time,
with WPQ physical scale scores and KHQ physical limitations
score both decreasing at three months and the WPQ Index and
KHQ role limitations also both decreasing at three months.
CONCLUSION: Results suggest that the WPQ is a valid
measure of work productivity in patients with OAB.
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OBJECTIVES: To assess risk indicators for self-reported joint
pain and motion limitation outcomes in hemophilia patients.
METHODS: The Hemophilia Utilization Group Study (HUGS)
examines prospectively the cost and burden of hemophilia,
including arthropathy, quality of life, and economic impact in
patients aged 2 to 65. Parents/patients completed a standardized
interview, including factor use patterns and assessment of joint
pain and motion limitation. Clinical chart reviews were per-
formed to identify the presence of inhibitor antibodies and hemo-
philia severity. Logistic regression was used to evaluate the
association between the factors from the Health Behavioral
Model (predisposing, enabling, need, and health behavior) and
the likelihood of joint pain or motion limitation. RESULTS: Of
the 128 patients with complete outcome data, 70(55%) were
adults, 32(25%) reported joint pain most or all the time,
49(39%) reported severe motion limitation in at least one joint.
Mean age was 23.8 (16.2) years. Risk indicators associated with
joint pain were: 1) predisposing: increasing age (OR = 1.1; 95%
CI = 1.03, 1.1); parent/patient not married/without partner (OR
= 5.7; 1.8, 18.3), and 2) enabling: increasing number of prob-
lems getting care at the hemophilia treatment center (OR = 1.9;
1.03, 3.6). No association was found in need (ever had inhibitor)
and health behaviors (use of factor). Risk indicators associated
with severe motion limitation were: 1) predisposing: increasing
age (OR = 1.1; 95% CI = 1.07, 1.2); parent/patient not
married/without partner (OR = 3.9; 1.3, 12.2); severe hemo-
philia (OR = 21.0; 2.8, 158.9). CONCLUSION: Increasing age,
lack of a support system and more severe hemophilia are useful
characteristics for clinicians to identify patients at greater risk
for joint pain and limitation. Early identiﬁcation of these factors,
which are a major source of disability, may be helpful in avoid-
ing decreased health status and increased medical costs. Address-
ing barriers to receipt of care is of particular import for those
most at risk.
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OBJECTIVES: Abnormal uterine bleeding (AUB) affects up to
30% of women of reproductive age. The purpose of this study
is to quantitatively estimate the impact of AUB on health-related
quality of life (HRQoL). METHODS: A systematic literature
review of studies reporting the impact of AUB or its treatment
on HRQoL published from 1980 to 2005 was conducted from
the PubMed database. We conducted a meta-analysis of eight
studies providing HRQoL scores derived from the 36-item Short
Form Health Survey Questionnaire (SF-36); only baseline SF-36
scores prior to treatment were analyzed. Both random-effect and
ﬁxed-effect models were created and used. The scores were com-
pared with US national norms (weighted average across age
groups 18–24, 25–34, 35–44, and 45–54, obtained from the SF-
36 Health Survey Manual & Interpretation Guide). A subgroup
analysis was conducted to examine whether or not the SF-36
scores differ according to the mean age of each subgroup.
RESULTS: Women with AUB had lower SF-36 scores (worse
health) in all eight subscales; the most signiﬁcantly affected were
Physical Role Functioning and Emotional Role Functioning sub-
scales, which relate to work productivity and other daily activi-
ties. The scores in these two dimensions were approximately 20
points lower than the US population norms (60.3 vs. 84.0 and
62.3 vs. 81.1; highest score = 100). In 6 of the 8 subscales, the
scores for AUB were below the 25th percentile of those for US
national norms (Physical Functioning, Physical Role Function-
ing, Pain, Vitality, Social Functioning, and Emotional Role Func-
tioning). The subgroup analysis suggested that older women had
lower SF-36 scores than younger women; however, the small
number of studies precludes the forming of a deﬁnitive conclu-
sion. CONCLUSIONS: AUB has a signiﬁcant impact on
women’s HRQoL. Treatment for AUB should consider improv-
ing HRQoL status.
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OBJECTIVES: To evaluate the impact of a 90-day retail program
on prescription drug expenditures in a pharmacy beneﬁt man-
agement organization. METHODS: This study was based on
prescription records from pharmacy claims database for a time
period from January 1, 2003 to August 31, 2005. A retrospec-
tive cohort study design with one-year pre period and one-year
post period was employed. Propensity scores were used to match
the study and control clients in terms of patient and client char-
acteristics. Per prescription cost, per member per month (PMPM)
total, plan and member costs and generic utilization rate were
the targeted outcomes. RESULTS: The study group included 25
clients (106,718 lives) enrolled in 90-day retail program, and the
